Skip to content
Tool

Stock screener

Filter the 3753 US stocks StockVane tracks, then sort by any column. Results carry the same Quant Rating shown on each stock’s page.

Updated 6 minutes ago
176Matches
$884.09BCombined market cap
19.4Median P/E
-3.31%Avg move today
Reset

Six factor filters use background-computed relative grades. Stocks missing a selected factor are excluded; these are not return forecasts. Computed: 2026-11-22 08:27 UTC. Included in Premium and new-account trials

176 matches

Company60dLastChg%Mkt capP/EYield1-yrQuant ↑
Aktis OncologyAKTS16.15-1.52%$901.14M------D 0
ApnimedAPMD16.09-6.70%$669.84M4.13----C 0
Attovia TherapeuticsATTO15.10-3.08%$690.26M------C 0
Avalyn PharmaAVLN28.40-1.05%$1.26B------C 0
ELECTRA THERAPEUTICS INCETRA8.11-9.28%$509.85M------C 0
Latigo BiotherapeuticsLTGO13.00-1.81%$861.89M------C 0
Odyssey TherapeuticsODTX16.96-7.52%$815.23M------C 0
SpyGlass PharmaSGP30.43-1.14%$1.02B------C 0
SL ScienceSLBT0.55-5.37%$308.42M-----94.8%E 0
Seaport TherapeuticsSPTX18.05-1.47%$966.23M------C 0
Theravance Biopharma(Delisted)TBPH0.000.00%$884.18M16.38----C 0
First Tracks BiotherapeuticsTRAX41.64-6.34%$1.75B------C 0
Parabilis MedicinesPBLS27.44-0.67%$3.44B------C 0
AtaiBeckleyATAI0.000.00%$0------C 0
Adarx PharmaceuticalsADRX12.79-9.68%$1.42B------C 0
Braveheart BioBRVE20.39+5.81%$1.83B------C 0
Generate BiomedicinesGENB9.54-8.00%$1.23B------C 0
Phathom PharmaceuticalsPHAT4.66-8.27%$378.82M-----68.9%E 2
Alnylam PharmaceuticalsALNY143.82-2.71%$19.26B7.48---67.0%E 2
Mineralys TherapeuticsMLYS13.66-3.53%$1.21B-----67.4%E 2
Avalo TherapeuticsAVTX6.76+0.15%$390.88M-----62.1%E 3
Janux TherapeuticsJANX10.08-2.04%$616.73M-----65.0%E 3
OculisOCS7.06-5.11%$437.15M-----63.3%E 3
Olema PharmaceuticalsOLMA7.02-1.82%$615.00M-----69.7%E 3
Ionis PharmaceuticalsIONS26.58-2.35%$4.43B-----65.1%E 3
Ascentage PharmaAAPG11.97-3.78%$1.12B-----60.9%E 3
MiMedxMDXG3.05-1.93%$445.07M-----54.9%E 5
Sana BiotechnologySANA1.59-8.62%$476.42M-----51.7%E 5
NewAmsterdam PharmaNAMS18.41-5.64%$2.21B-----51.9%E 5
Structure TherapeuticsGPCR16.13-5.78%$1.15B-----53.0%E 5
Nektar TherapeuticsNKTR30.20-7.19%$1.03B-----44.4%E 6
ArdelyxARDX2.99-2.29%$751.60M-----44.8%E 7
CorMedixCRMD5.27+3.74%$419.16M8.23---45.6%E 7
Nuvation BioNUVB3.80-0.26%$1.34B-----45.6%E 7
Syndax PharmaceuticalsSNDX8.72-4.49%$785.05M-----50.0%E 7
Ultragenyx PharmaceuticalRARE16.48-4.30%$1.68B-----50.9%E 7
ArriVent BioPharmaAVBP10.52-6.57%$544.13M-----48.3%E 7
Bicara TherapeuticsBCAX8.44-7.46%$560.31M-----53.2%E 8
Gyre TherapeuticsGYRE4.21-6.86%$460.79M-----44.2%E 8
ImmaticsIMTX5.77-3.03%$878.58M-----43.4%E 8
Legend BiotechLEGN15.25-5.28%$2.96B-----45.9%E 8
CelcuityCELC53.35-5.26%$2.62B-----45.3%E 8
ValnevaVALN5.16-3.82%$490.86M-----40.1%E 9
AlumisALMS3.96-8.55%$514.09M-----45.8%E 10
Kura OncologyKURA6.91-5.99%$634.88M-----38.1%E 10
Summit TherapeuticsSMMT9.95-5.87%$7.96B-----38.5%E 10
Recursion PharmaceuticalsRXRX2.45-9.93%$1.53B-----41.2%E 10
Oric PharmaceuticalsORIC7.36-4.42%$764.94M-----36.7%E 11
RegenxbioRGNX7.16-0.28%$473.44M-----39.3%E 12
Abivax S.A.ABVX73.20-9.24%$6.41B-----38.5%E 12
VerastemVSTM6.33-7.73%$797.67M-----36.7%D 14
InsmedINSM141.33-2.17%$31.01B-----28.9%D 14
Viking TherapeuticsVKTX24.77-4.14%$3.16B-----27.7%E 14
ImmunocoreIMCR26.41-0.83%$1.36B-----32.9%E 14
Pharming GroupPHAR11.54-5.18%$816.78M34.97---29.0%D 15
PTC TherapeuticsPTCT56.42-3.27%$4.71B-----28.1%D 17
ACADIA PharmaceuticalsACAD17.11-2.73%$2.96B8.07---27.4%D 17
Dyne TherapeuticsDYN15.50-3.31%$2.90B-----26.8%D 17
AnnexonANNX3.10-9.09%$591.37M-----27.4%D 18
InventivaIVA3.14-8.99%$750.78M-----27.0%D 18

Showing the first 60 of 176. Add a filter to narrow it.

Reference only, not investment advice. A screen is a starting point, not a buy list. Quant Rating method: Data & Methodology.